Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.

Malaria journal - 1 Apr 2011

Ranjitkar Samir, Schousboe Mette L, Thomsen Thomas Thyge, Adhikari Madhav, Kapel Christian M O, Bygbjerg Ib C, Alifrangis Michael

Abstract excerpt

BACKGROUND: Sulphadoxine-pyrimethamine (SP) and chloroquine (CQ) have been used in treatment of falciparum and vivax malaria in Nepal. Recently, resistance to both drugs have necessitated a change towards artemisinin combination therapy (ACT) against Plasmodium falciparum in highly endemic areas. However, SP is still used against P. falciparum infections in low endemic areas while CQ is used in suspected cases in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Artemisinins
Share to Chloroquine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Combinations

Share to Malaria, Vivax

Share to Plasmodium vivax

Share to Pyrimethamine

Share to Sulfadoxine

Source

Open in PubMed Open full text

Identifiers

PMID: 21457533
DOI: 10.1186/1475-2875-10-75
PMCID: PMC3080351

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.PMID 21457533Read ↗

Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, SenegalSemantic proximity Read ↗

Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, IndiaSemantic proximity Read ↗

Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan.Semantic proximity Read ↗

Prevalence of molecular markers of sulfadoxine–pyrimethamine and artemisinin resistance in Plasmodium falciparum from PakistanSemantic proximity Read ↗

A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.Semantic proximity Read ↗

Surveillance of molecular markers of antimalarial drug resistance in Plasmodium falciparum and Plasmodium vivax in Federally Administered Tribal Area (FATA), Pakistan.Semantic proximity Read ↗

Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.Semantic proximity Read ↗

Plasmodium falciparum: higher incidence of molecular resistance markers for sulphadoxine than for pyrimethamine in Kasangati, Uganda.Semantic proximity Read ↗

High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria.Semantic proximity Read ↗

Genotyping of Plasmodium falciparum using antigenic polymorphic markers and to study anti-malarial drug resistance markers in malaria endemic areas of Bangladesh.Semantic proximity Read ↗

Prevalence of Molecular Markers of Plasmodium Falciparum Resistance to Proguanil and Pyrimethamine in Children with Haemoglobin Phenotypes SS and AA in Benin City, Nigeria.Semantic proximity Read ↗

Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.